Haugh, A., Dubay, J. W., Duus, E. M., Bellayr, I., Aguilar, L. K., Molinaro, A. M., Trivedi, A., Liu, W., Konduri, V., Decker, W. K., Sullivan, R. J. (2026). A phase I/II clinical study of DOC1021 (dubodencel) dendritic cell immunotherapy for refractory melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9602